Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tax Incentives For Biomedical Industry Are Focus Of Multiple Bills In Congress

Executive Summary

Tax incentives for the life sciences industry have a lot of allies in Congress, but any traction on reforms probably awaits broader movement on major tax or economic legislation

You may also be interested in...



Tax Incentives To Spur Innovation: BIO's "Big Ideas" Beyond FDA

Tax Incentives To Spur Innovation: BIO's "Big Ideas" Beyond FDA

NIH Move To Consolidate Translational Programs Is Not The Big Shakeup It's Made Out To Be, Agency Says

The National Institutes of Health's proposed National Center for Advancing Translational Sciences reflects neither a shakeup of existing NIH programs nor any intent to create an agency that functions like a drug company, NIH officials say.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel